Medline Inc. (MDLN)
NASDAQ: MDLN · Real-Time Price · USD
32.83
-1.08 (-3.18%)
Aug 20, 2026, 1:33 PM EDT - Market open
Medline Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Net Income | 693 | 1,159 | 1,200 | 234 | -25 |
Depreciation & Amortization | 1,024 | 1,011 | 977 | 951 | 933 |
Other Amortization | 53 | 59 | 57 | 80 | 85 |
Loss (Gain) From Sale of Assets | - | - | - | - | 6 |
Stock-Based Compensation | 94 | 76 | 61 | 78 | 64 |
Provision & Write-off of Bad Debts | 22 | 54 | 63 | 8 | 29 |
Other Operating Activities | 711 | 168 | 86 | 135 | 14 |
Change in Accounts Receivable | -354 | -355 | -256 | -153 | -376 |
Change in Inventory | -220 | -264 | -545 | 444 | -195 |
Change in Accounts Payable | 117 | 73 | 106 | 136 | -103 |
Change in Other Net Operating Assets | -148 | -237 | 20 | -228 | -245 |
Operating Cash Flow | 1,992 | 1,744 | 1,769 | 1,685 | 187 |
Operating Cash Flow Growth | 30.37% | -1.41% | 4.98% | 801.07% | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Capital Expenditures | -446 | -480 | -364 | -285 | -254 |
Cash Acquisitions | - | 6 | -1,126 | -16 | -17 |
Investment in Securities | -350 | - | - | - | 7 |
Other Investing Activities | - | - | -3 | -11 | - |
Investing Cash Flow | -796 | -474 | -1,493 | -312 | -264 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Short-Term Debt Issued | - | 179 | 166 | - | 80 |
Long-Term Debt Issued | - | 7,569 | 15,932 | - | - |
Total Debt Issued | 12,302 | 7,748 | 16,098 | - | 80 |
Short-Term Debt Repaid | - | -179 | -166 | - | -80 |
Long-Term Debt Repaid | - | -11,661 | -15,995 | -77 | -61 |
Total Debt Repaid | -16,413 | -11,840 | -16,161 | -77 | -141 |
Net Debt Issued (Repaid) | -4,111 | -4,092 | -63 | -77 | -61 |
Issuance of Common Stock | 7,049 | 7,048 | - | - | - |
Repurchase of Common Stock | -1,993 | -2,003 | -20 | - | - |
Common Dividends Paid | -215 | -518 | -1,518 | -114 | -23 |
Other Financing Activities | -166 | -36 | -12 | - | - |
Financing Cash Flow | 564 | 399 | -1,613 | -191 | -84 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Foreign Exchange Rate Adjustments | -15 | 23 | 2 | 4 | -30 |
Net Cash Flow | 1,745 | 1,692 | -1,335 | 1,186 | -191 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Free Cash Flow | 1,546 | 1,264 | 1,405 | 1,400 | -67 |
Free Cash Flow Growth | 41.97% | -10.04% | 0.36% | - | - |
Free Cash Flow Margin | 5.16% | 4.45% | 5.51% | 6.03% | -0.31% |
Free Cash Flow Per Share | 1.76 | 1.56 | 0.08 | 0.08 | - |
Levered Free Cash Flow | 1,058 | 791.25 | 759.5 | - | - |
Unlevered Free Cash Flow | 1,493 | 1,323 | 1,418 | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash Interest Paid | 796 | 944 | 1,022 | 1,126 | 800 |
Cash Income Tax Paid | 33 | 62 | 101 | 52 | 54 |
Change in Working Capital | -605 | -783 | -675 | 199 | -919 |